Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SELAS GRANDE PHARMACIE DU CENTRE : revenue, balance sheet and financial ratios

SELAS GRANDE PHARMACIE DU CENTRE is a French company founded 32 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in CASTELNAUDARY (11400), this company of category PME shows in 2023 a revenue of 3.2 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELAS GRANDE PHARMACIE DU CENTRE (SIREN 392402061)
Indicator 2025 2024 2023 2019 2018
Revenue N/C N/C 3 163 643 € N/C N/C
Net income -258 485 € 144 006 € 167 266 € 54 641 € 43 623 €
EBITDA N/C N/C 194 706 € N/C N/C
Net margin N/C N/C 5.3% N/C N/C

Revenue and income statement

In 2025, SELAS GRANDE PHARMACIE DU CENTRE records a net loss of 258 k€. This deficit will reduce equity on the balance sheet.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-258 485 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 546%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 13%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

545.581%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

12.617%

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

16.1%

Solvency indicators evolution
SELAS GRANDE PHARMACIE DU CENTRE

Sector positioning

Debt ratio
545.58 2025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Watch +9 pts over 3 years

In 2025, the debt ratio of SELAS GRANDE PHARMACIE DU... (545.58) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.

Financial autonomy
12.62% 2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Watch

In 2025, the financial autonomy of SELAS GRANDE PHARMACIE DU... (12.6%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.

Repayment capacity
5.28 years 2023
2023
Q1: 0.95 years
Med: 3.59 years
Q3: 7.48 years
Average

In 2023, the repayment capacity of SELAS GRANDE PHARMACIE DU... (5.28) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 111.71. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

111.709

Liquidity indicators evolution
SELAS GRANDE PHARMACIE DU CENTRE

Sector positioning

Liquidity ratio
111.71 2025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Watch +7 pts over 3 years

In 2025, the liquidity ratio of SELAS GRANDE PHARMACIE DU... (111.71) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.

Interest coverage
2.03x 2023
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Average

In 2023, the interest coverage of SELAS GRANDE PHARMACIE DU... (2.0x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2025) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2025) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2025) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2025) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SELAS GRANDE PHARMACIE DU CENTRE

Positioning of SELAS GRANDE PHARMACIE DU CENTRE in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELAS GRANDE PHARMACIE DU CENTRE with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELAS GRANDE PHARMACIE DU CENTRE

What is the revenue of SELAS GRANDE PHARMACIE DU CENTRE ?

The revenue of SELAS GRANDE PHARMACIE DU CENTRE in 2023 is 3.2 M€.

Is SELAS GRANDE PHARMACIE DU CENTRE profitable?

SELAS GRANDE PHARMACIE DU CENTRE recorded a net loss in 2025.

Where is the headquarters of SELAS GRANDE PHARMACIE DU CENTRE ?

The headquarters of SELAS GRANDE PHARMACIE DU CENTRE is located in CASTELNAUDARY (11400), in the department Aude.

Where to find the tax return of SELAS GRANDE PHARMACIE DU CENTRE ?

The tax return of SELAS GRANDE PHARMACIE DU CENTRE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELAS GRANDE PHARMACIE DU CENTRE operate?

SELAS GRANDE PHARMACIE DU CENTRE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.